Atlas Trials

A Study to Evaluate Effectiveness and Safety of Ponatinib in Patients With BCR-ABL Positive ALL in Standard Clinical Practice in Europe - "POSEIDON"

Clinical trial NCT03515785 · WITHDRAWN

Trial details

NCT number
NCT03515785
Sponsor
Incyte Biosciences International Sàrl
Status
WITHDRAWN
Study type
OBSERVATIONAL
BCR-ABL Positive Acute Lymphoblastic Leukemia
Start date
2018-12-31
Primary completion
2021-03-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.